Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations

DMD gene mutations have been associated with the development of Dystrophinopathies. Interestingly, it has been recently reported that DMD is involved in the development and progression of myogenic tumors, assigning DMD a tumor suppressor activity in these types of cancer. However, there are only few...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Luce, L.N., Abbate, M., Cotignola, J., Giliberto, F.
Formato: JOUR
Materias:
DMD
Dystrophin
Gene expression
Genetic alteration
Survival
dystrophin
Article
benign neoplasm
breast cancer
cancer growth
cancer prognosis
cancer survival
controlled study
disease association
DMD gene
gene expression regulation
gene identification
gene mutation
gene overexpression
genetic association
genetic disorder
microarray analysis
mutational analysis
non myogenic tumor
overall survival
RNA sequence
survival rate
survival time
tumor suppressor gene
uterus cancer
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_19492553_v8_n1_p145_Luce
Aporte de:
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Ejemplares similares